Waters Corporation (LON:0LTI)
| Market Cap | 17.18B |
| Revenue (ttm) | 2.32B |
| Net Income (ttm) | 483.81M |
| Shares Out | n/a |
| EPS (ttm) | 8.11 |
| PE Ratio | 35.50 |
| Forward PE | 27.58 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 728 |
| Average Volume | 215 |
| Open | 390.61 |
| Previous Close | 388.16 |
| Day's Range | 387.01 - 391.33 |
| 52-Week Range | 275.99 - 422.64 |
| Beta | 1.16 |
| RSI | 52.70 |
| Earnings Date | Feb 10, 2026 |
About Waters
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies soft... [Read more]
Financial Performance
In 2024, Waters's revenue was $2.96 billion, an increase of 0.07% compared to the previous year's $2.96 billion. Earnings were $637.83 million, a decrease of -0.69%.
Financial numbers in USD Financial StatementsNews
WAT Stock Upgraded by Wolfe Research to 'Outperform' | WAT Stock News
WAT Stock Upgraded by Wolfe Research to 'Outperform' | WAT Stock News
Waters Corporation (WAT) Upgraded by Wolfe Research Amid Merger Potential
Waters Corporation (WAT) Upgraded by Wolfe Research Amid Merger Potential
Why Is Waters (WAT) Up 6.9% Since Last Earnings Report?
Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Morgan Stanley Initiates Coverage on WAT with Equal-Weight Rating | WAT Stock News
Morgan Stanley Initiates Coverage on WAT with Equal-Weight Rating | WAT Stock News
Wednesday Sector Laggards: Healthcare, Industrial
Looking at the sectors faring worst as of midday Wednesday, shares of Healthcare companies are underperforming other sectors, showing a 0.2% loss. Within the sector, Waters Corp. (Symbol: WAT) and Bio...
Waters Corp (WAT)'s Winning Formula: Financial Metrics and Competitive Strengths
Waters Corp (WAT)'s Winning Formula: Financial Metrics and Competitive Strengths
Waters Corporation (WAT) Presents at Jefferies London Healthcare Conference 2025 Transcript
Waters Corporation (WAT) Jefferies London Healthcare Conference 2025 November 18, 2025 9:30 AM ESTCompany ParticipantsUdit Batra - President, CEO &...
Waters Corporation to Present at the Jefferies Global Healthcare Conference in London
MILFORD, Mass. , Nov. 11, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D.
Waters Boosts Lab Productivity and Sample Throughput with Launch of its Charged Aerosol Detector Designed for Empower Software
Drives efficiency and reliability in Quality Control and Development environments, integrating seamlessly with world-class Empower™ Chromatography Data System (CDS). Mitigates CDS communication errors...
Agree To Purchase Waters At $320, Earn 7% Annualized Using Options
Investors considering a purchase of Waters Corp. (Symbol: WAT) shares, but cautious about paying the going market price of $364.61/share, might benefit from considering selling puts among the alternat...
TD Cowen Raises Price Target for Waters (WAT) to $390 | WAT Stock News
TD Cowen Raises Price Target for Waters (WAT) to $390 | WAT Stock News
The London Company SMID Cap Vs. Russell 2500 Q3 2025 Top Contributors And Detractors
Armstrong World Industries, Inc. (AWI) shares outperformed in the quarter due to beating expectations, driven by favorable positioning in key verticals and strong operating leverage. Somnigroup Intern...
WAT Crosses Above Average Analyst Target
In recent trading, shares of Waters Corp. (Symbol: WAT) have crossed above the average analyst 12-month target price of $362.36, changing hands for $367.34/share. When a stock reaches the target an an...
Decoding Waters Corp (WAT): A Strategic SWOT Insight
Decoding Waters Corp (WAT): A Strategic SWOT Insight
Waters Corp (WAT) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance
Waters Corp (WAT) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance
Q3 2025 Waters Corp Earnings Call Transcript
Q3 2025 Waters Corp Earnings Call Transcript
Waters Corporation (WAT) Q3 2025 Earnings Call Transcript
Waters Corporation (WAT) Q3 2025 Earnings Call November 4, 2025 8:00 AM ESTCompany ParticipantsCaspar Tudor - Head of Investor RelationsUdit Batra -...
Waters Corp Q3 2025 Earnings: Revenue Surpasses Estimates at $800M, Non-GAAP EPS Beats at $3.40
Waters Corp Q3 2025 Earnings: Revenue Surpasses Estimates at $800M, Non-GAAP EPS Beats at $3.40
Waters Corp raises annual profit forecast on stronger lab equipment demand
Lab equipment maker Waters Corp raised its annual profit forecast on Tuesday, after beating third-quarter profit estimates on improved demand from biotech clients for its tools used in drug developmen...
Waters (WAT) Tops Q3 Earnings and Revenue Estimates
Waters (WAT) delivered earnings and revenue surprises of +5.92% and +2.59%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Waters Corp. Q3 Beats Street, Sees Q4 Below Market, Lifts FY25 Outlook
(RTTNews) - Waters Corp. (WAT), a provider of analytical instruments, separations technologies, and software, on Tuesday reported weak profit in its third quarter, while adjusted earnings and top line...
Waters Corporation (WAT) Projects Q4 Revenue Increase and EPS Growth
Waters Corporation (WAT) Projects Q4 Revenue Increase and EPS Growth
Waters (WAT) Exceeds Q3 Revenue Expectations with Strong Pharma Growth
Waters (WAT) Exceeds Q3 Revenue Expectations with Strong Pharma Growth
Waters beats top-line and bottom-line estimates; initiates Q4 and raises FY25 outlook
Waters (WAT) posts strong Q3 results: Non-GAAP EPS $3.40 (+$0.20) and revenue up 8.1% to $800M.
Waters Corporation (NYSE: WAT) Reports Third Quarter 2025 Financial Results
Highlights Sales of $800 million exceeded guidance; grew 8% as reported and 8% in constant currency Delivered GAAP EPS of $2.50 and non-GAAP EPS of $3.40, which reflects strong, 16% growth in Adjusted...